ArticleCancer immunology, immunotherapy : CII2025
Stereotactic ablative radiotherapy-driven immunosuppression is associated with poorer progression-free survival in cancer patients.
Jessica Oliver et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.